Hemodialysis Vascular Grafts Market is expected to reach US$ 285.2 Mn by 2026
Added: (Mon Feb 18 2019)
Pressbox (Press Release) -
The latest market report published by Credence Research, Inc. “Global Hemodialysis Vascular Grafts Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global hemodialysis vascular grafts market is expected to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 expanding at a CAGR of 4.3% from 2018 to 2026.
Browse the full report Hemodialysis Vascular Grafts Market 2018 – 2026 report at https://www.credenceresearch.com/report/hemodialysis-vascular-grafts-market
Market Insights
End stage renal disease (ESRD) is a medical condition in which the kidney functions only 10% of its natural ability to perform excretion of toxic material from the human blood. When the glomerular filtration rate of the kidney is <15 ml/min/1.73 m2, patient is reported with end stage renal failure. Diabetes and hypertension are the chief causative factors in chronic kidney disease. Chronic kidney disease has a global prevalence rate between 11 to 13% in stage 3 ESRD. The role of vascular grafts in hemodialysis procedure is to attain blood flow from one area to the other by connecting blood vessels.
Polyurethane is mixed in different concentration to achieve vascular graft with improved tensile strength and larger inner luminal diameter to promote smooth blood transfusion during hemodialysis procedure. Polytetrafluoroethylene currently dominates the raw material segment for hemodialysis vascular grafts market. Its inherent features such as high adhesion, excellent native fistula pliability and reimburesemnt scenario drive the market growth. Bioengineered materials will be the latest trendsetter during the forecast period due to improved material characteristics which prevent infection, hemorrhage and graft rejection occurring during hemodialysis procedure in patients suffering with chronic kidney disease.
Download Sample research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59569
With a market share of 36% North America is the largest regional market in hemodialysis vascular grafts market. The properties influencing its dominant growth are increasing geriatric population suffering with end stage renal disease and higher healthcare expenditure. Existence of market leaders such as C.R.Bard, Inc., Terumo Medical Corporation and CryoLife, Inc. etc. further propel the hemodialysis vascular grafts market in the North America region. Europe currently holds 28% share owing to features such as supportive reimbursement scenario associated with hemodialysis vascular grafts and increasing demand for hemodialysis procedures compared to intraperitoneal dialysis in patients suffering with chronic kidney disease. Asia Pacific represents 20% share and is set to engrave positive growth in the near future due to proactive government policies to fight renal disease and rapid growth in medical tourism.
Pharmaceutical companies manufacturing hemodialysis vascular grafts are C.R.Bard, Inc., CryoLife, Inc., Getinge AB., InnAVasc Medical, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Proteon Therapeutics, Inc., Terumo Medical Corporation, Vascular Genesis and W.L.Gore Associates.
Key Market Movements:
Increasing morbidity associated with hemodialysis procedures in patients suffering with end stage renal diseases
Different blends of synthetic polymers are mixed e.g. polyurethane and polytetrafluoroethylene to achieve the desired native fistula pliability and adhesion properties
Technical innovations in bioengineered raw materials to drastically reduce infection, graft rejection and hemorrhage occurring in hemodialysis procedures
Do inquiry before purchase the Industry Research Report @ https://www.credenceresearch.com/inquiry-before-buying/59569
TOC :
Chapter 3. Hemodialysis Vascular Grafts Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Hemodialysis Vascular Grafts Market, by Key Players, 2017
Chapter 4. Global Hemodialysis Vascular Grafts Market, by Raw Material
4.1. Overview
4.2. Polyurethane
4.3. Polyester
4.4. Polytetrafluoroethylene
4.5. Biological Material
Chapter 5. Global Hemodialysis Vascular Grafts Market, by Geography
5.1. Overview
5.2. North America Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.2.1. North America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.2.2. North America Hemodialysis Vascular Grafts Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.3.1. Europe Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.3.2. Europe Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.5.1. Latin America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.6.1. MEA Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.6.2. MEA Hemodialysis Vascular Grafts Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. C.R.Bard, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. CryoLife, Inc.
6.3. Getinge AB.
6.4. InnAVasc Medical, Inc. ...
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith (Global Sales Manager)
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: https://www.credenceresearch.com